By: Dyana Williams, Client Manager, Lighthouse RCM Solutions Don’t you love the way we use the phrase “perfect storm” to describe adverse situations? It does bring to mind the way that a combination of events can coalesce into something much greater than the sum of...
By: Tami Shaw, Client Manager, RCM Solutions In the Spring of 2022, states participating in a Medicare MAC utilizing the MolDX program were subject to changes requiring registration for Infectious Disease testing if the panel in question is a lab developed test (LDT)....
In a win for laboratory innovation, the VALID Act, which would have created a new risk-based framework for regulating lab developed tests (LDTs), was excluded from the year-end omnibus spending package recently finalized by Congress, meaning the legislation...
Entering into an agreement for medical billing services is an important process for any clinical lab or pathology group who does not have this service provided by a hospital or other partner. But what metrics and capabilities should a medical group or lab be looking...
The 2023 Medicare Physician Fee Schedule Final Rule was released by CMS late Thursday, Nov 3. After two consecutive years of Congress delaying a number of anticipated reimbursement cuts due to the impact of the COVID pandemic, it now appears these previously planned...
Lighthouse’s RCM Solutions Team was recently made aware that Blue Cross Blue Shield of Alabama is conducting overpayment reviews for infectious disease testing that could result in takebacks for impacted clinical laboratories. The message (available below)...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy